H

Huakang Biomedical Holdings Co Ltd
HKEX:8622

Watchlist Manager
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Watchlist
Price: 0.375 HKD -2.6% Market Closed
Market Cap: HK$187.7m

Relative Value

8622 doesn't have a meaningful market cap.

The Relative Value of one Huakang Biomedical Holdings Co Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 0.375 HKD, Huakang Biomedical Holdings Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Huakang Biomedical Holdings Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Huakang Biomedical Holdings Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
HK
Huakang Biomedical Holdings Co Ltd
HKEX:8622
187.7m HKD 6.5 -35.2 -26.2 -26.2
US
Medline Inc
NASDAQ:MDLN
58.5B USD 0 0 0 0
JP
Hoya Corp
TSE:7741
8.9T JPY 9.8 35.7 25.7 30.9
CH
Alcon AG
SIX:ALC
30.3B CHF 3.8 36.9 15.3 29.7
DK
Coloplast A/S
CSE:COLO B
111.8B DKK 4 30.8 14.4 17.1
US
Align Technology Inc
NASDAQ:ALGN
12.7B USD 3.2 33.6 15.3 19.4
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP 2.7 29.2 13 21.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY 9.4 26 23.5 23.5
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD 1.2 -19.1 19.2 90.7
CH
Ypsomed Holding AG
SIX:YPSN
4B CHF 5 20.3 13.2 17.9
KR
HLB Inc
KOSDAQ:028300
6.9T KRW 85 -31.2 -72.3 -68.4
P/E Multiple
Earnings Growth PEG
HK
H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Average P/E: 30.4
Negative Multiple: -35.2
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
35.7
13%
2.7
CH
Alcon AG
SIX:ALC
36.9
25%
1.5
DK
Coloplast A/S
CSE:COLO B
30.8
22%
1.4
US
Align Technology Inc
NASDAQ:ALGN
33.6
27%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
29.2
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26
9%
2.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.1 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
20.3
32%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -31.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
HK
H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Average EV/EBITDA: 17.4
Negative Multiple: -26.2
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
25.7
11%
2.3
CH
Alcon AG
SIX:ALC
15.3
8%
1.9
DK
Coloplast A/S
CSE:COLO B
14.4
8%
1.8
US
Align Technology Inc
NASDAQ:ALGN
15.3
13%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
13
10%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.5
15%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
19.2
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
13.2
21%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -72.3 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
HK
H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Average EV/EBIT: 31.3
Negative Multiple: -26.2
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
30.9
N/A N/A
CH
Alcon AG
SIX:ALC
29.7
23%
1.3
DK
Coloplast A/S
CSE:COLO B
17.1
8%
2.1
US
Align Technology Inc
NASDAQ:ALGN
19.4
16%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
21.1
22%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.5
11%
2.1
CA
Bausch + Lomb Corp
NYSE:BLCO
90.7
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
17.9
29%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -68.4 N/A N/A